Cargando…
FOXC1: an emerging marker and therapeutic target for cancer
The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652000/ https://www.ncbi.nlm.nih.gov/pubmed/28288141 http://dx.doi.org/10.1038/onc.2017.48 |
_version_ | 1783272985791037440 |
---|---|
author | Han, Bingchen Bhowmick, Neil Qu, Ying Chung, Stacey Giuliano, Armando E. Cui, Xiaojiang |
author_facet | Han, Bingchen Bhowmick, Neil Qu, Ying Chung, Stacey Giuliano, Armando E. Cui, Xiaojiang |
author_sort | Han, Bingchen |
collection | PubMed |
description | The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC as well as the implications of these new findings in cancer diagnosis and treatment. |
format | Online Article Text |
id | pubmed-5652000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-56520002017-10-23 FOXC1: an emerging marker and therapeutic target for cancer Han, Bingchen Bhowmick, Neil Qu, Ying Chung, Stacey Giuliano, Armando E. Cui, Xiaojiang Oncogene Article The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC as well as the implications of these new findings in cancer diagnosis and treatment. 2017-03-13 2017-07-13 /pmc/articles/PMC5652000/ /pubmed/28288141 http://dx.doi.org/10.1038/onc.2017.48 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Han, Bingchen Bhowmick, Neil Qu, Ying Chung, Stacey Giuliano, Armando E. Cui, Xiaojiang FOXC1: an emerging marker and therapeutic target for cancer |
title | FOXC1: an emerging marker and therapeutic target for cancer |
title_full | FOXC1: an emerging marker and therapeutic target for cancer |
title_fullStr | FOXC1: an emerging marker and therapeutic target for cancer |
title_full_unstemmed | FOXC1: an emerging marker and therapeutic target for cancer |
title_short | FOXC1: an emerging marker and therapeutic target for cancer |
title_sort | foxc1: an emerging marker and therapeutic target for cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652000/ https://www.ncbi.nlm.nih.gov/pubmed/28288141 http://dx.doi.org/10.1038/onc.2017.48 |
work_keys_str_mv | AT hanbingchen foxc1anemergingmarkerandtherapeutictargetforcancer AT bhowmickneil foxc1anemergingmarkerandtherapeutictargetforcancer AT quying foxc1anemergingmarkerandtherapeutictargetforcancer AT chungstacey foxc1anemergingmarkerandtherapeutictargetforcancer AT giulianoarmandoe foxc1anemergingmarkerandtherapeutictargetforcancer AT cuixiaojiang foxc1anemergingmarkerandtherapeutictargetforcancer |